{"id":799504,"date":"2025-01-10T08:08:46","date_gmt":"2025-01-10T13:08:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/"},"modified":"2025-01-10T08:08:46","modified_gmt":"2025-01-10T13:08:46","slug":"bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/","title":{"rendered":"BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week"},"content":{"rendered":"<div class=\"mw_release\">\n<p>GAITHERSBURG, Md., Jan.  10, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1i3-Cwtcd20Qa6SSgVaWRP6QnaMjyEAGtyItrBAbTeMv_XYRBKzpC9XOeJeC1wikZQEXPKOwDR3mxIg5eqBhRnodwbQNww2w_Pu0MbSfiHY=\" rel=\"nofollow\" target=\"_blank\">BullFrog AI Holdings, Inc.<\/a> (NASDAQ: BFRG; BFRGW) (&#8220;BullFrog AI&#8221; or the &#8220;Company&#8221;), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its participation in the TechBio track at Biotech Showcase and RESI JPM, both taking place during the annual JP Morgan Healthcare Conference in San Francisco, January 13\u201316, 2025.<\/p>\n<p>At both Biotech Showcase and RESI JPM, BullFrog AI will highlight its proprietary BullFrog Data Networks<sup>\u00ae<\/sup>, a data insights tool powered by the bfLEAP\u2122 platform. BullFrog Data Networks<sup>\u00ae<\/sup> evaluate high-dimension, multi-modal data in specific disease indications, providing a customized, visual representation of previously unknown relationships and pathways. The networks leverage a wide range of data inputs, including publicly available datasets such as the Human Cell Atlas (HCA), The Cancer Genome Atlas (TCGA), and Gene Expression Omnibus (GEO), as well as proprietary or custom data sources.<\/p>\n<p>BullFrog Data Networks<sup>\u00ae<\/sup> address a key challenge faced by pharmaceutical and biotechnology companies: turning vast and complex datasets into actionable insights. The platform uses machine learning to holistically analyze data, revealing hidden insights that manual methods cannot uncover. These insights are presented in an intuitive visual format that enables users to explore individual nodes or clusters, examine relationships, and derive actionable conclusions.<\/p>\n<p>BullFrog AI has demonstrated proof of concept for BullFrog Data Networks<sup>\u00ae<\/sup> in its own research and development pipeline, focusing on colorectal cancer and multiple neuropsychiatric indications. These networks have a wide range of applications, including target identification and validation, understanding mechanisms of action, optimizing clinical trials, and drug repurposing. By accelerating the generation of novel insights, BullFrog Data Networks<sup>\u00ae<\/sup> aim to transform approaches to drug development by reducing timelines and improving outcomes.<\/p>\n<p>Powered by the bfLEAP\u2122 platform, BullFrog Data Networks<sup>\u00ae<\/sup> are purpose-built to deliver answers to critical questions throughout the drug development lifecycle. From early target discovery to understanding drug safety and tolerability, the networks can help streamline development processes and optimize clinical trial design by identifying suitable patient populations for the appropriate trials. BullFrog Data Networks<sup>\u00ae<\/sup> represent an advancement in the Company&#8217;s mission to revolutionize drug discovery and development.<\/p>\n<p>\n        <strong>About BullFrog AI<\/strong>\n      <\/p>\n<p>BullFrog AI leverages Artificial Intelligence and machine learning to advance drug discovery and development. Through collaborations with leading research institutions, BullFrog AI uses causal AI in combination with its proprietary bfLEAP\u2122 platform to analyze complex biological data, aiming to streamline therapeutics development and reduce failure rates in clinical trials.<\/p>\n<p>For more information visit BullFrog AI at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eIdu6S67QFh1CQQawehCaqddTsz5L7tqnrSEE0szXyPgB50DKwpAfJSC8LA9_hesALz3Ji5aHhg--NW7LZJ0pLuVZTEuoqFSkKmUb3E0GvA=\" rel=\"nofollow\" target=\"_blank\">https:\/\/bullfrogai.com<\/a><\/p>\n<p>\n        <strong>Safe Harbor Statement<\/strong>\n      <\/p>\n<p>This press release contains forward-looking statements. We base these forward-looking\u00a0statements on our expectations and projections about future events, which we derive from\u00a0the information currently available to us. Such forward-looking statements relate to future\u00a0events or our future performance, including: our financial performance and projections; our\u00a0growth in revenue and earnings; and our business prospects and opportunities. You can\u00a0identify forward-looking statements by those that are not historical in nature, particularly\u00a0those that use terminology such as &#8220;may,&#8221; &#8220;should,&#8221; \u201ccould,\u201d \u201cwill,\u201d &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;contemplates,&#8221;\u00a0&#8220;estimates,&#8221; &#8220;believes,&#8221; &#8220;plans,&#8221; &#8220;projected,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; or &#8220;hopes&#8221; or the negative\u00a0of these or similar terms. In evaluating these forward-looking statements, you should\u00a0consider various factors, including: our ability to change the direction of the Company; our\u00a0ability to keep pace with new technology and changing market needs; and the competitive\u00a0environment of our business. These and other factors may cause our actual results to differ\u00a0materially from any forward-looking statement. Forward-looking statements are only\u00a0predictions. The forward-looking events discussed in this press release and other\u00a0statements made from time to time by us or our representatives, may not occur, and actual\u00a0events and results may differ materially and are subject to risks, uncertainties, and\u00a0assumptions about us. We are not obligated to publicly update or revise any forward-looking\u00a0statement, whether as a result of uncertainties and assumptions, the forward-looking events\u00a0discussed in this press release and other statements made from time to time by us or our\u00a0representatives might not occur.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>Dave Gentry<br \/>RedChip Companies, Inc.<br \/>1-407-644-4256<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fRJgIyAGxrv6zlac2oOp2R_M9HL_G7wpN2nSVQhRJgrAwLgB-f_JPsAC0LzCWzTvO7ZCqTs82QDXLa-FgoWiFQ==\" rel=\"nofollow\" target=\"_blank\">BFRG@redchip.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTg4MSM2Njg4MDk2IzIyNTU4NDk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDUxMDgxODMtNzlhZi00YjdmLWJlZDAtNDFlNDRmNDZiYTZmLTEyNjczOTg=\/tiny\/BullFrog-AI-Holdings-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>GAITHERSBURG, Md., Jan. 10, 2025 (GLOBE NEWSWIRE) &#8212; BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (&#8220;BullFrog AI&#8221; or the &#8220;Company&#8221;), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its participation in the TechBio track at Biotech Showcase and RESI JPM, both taking place during the annual JP Morgan Healthcare Conference in San Francisco, January 13\u201316, 2025. At both Biotech Showcase and RESI JPM, BullFrog AI will highlight its proprietary BullFrog Data Networks\u00ae, a data insights tool powered by the bfLEAP\u2122 platform. BullFrog Data Networks\u00ae evaluate high-dimension, multi-modal data in specific disease indications, providing a customized, visual representation of previously unknown relationships and pathways. The networks &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-799504","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GAITHERSBURG, Md., Jan. 10, 2025 (GLOBE NEWSWIRE) &#8212; BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (&#8220;BullFrog AI&#8221; or the &#8220;Company&#8221;), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its participation in the TechBio track at Biotech Showcase and RESI JPM, both taking place during the annual JP Morgan Healthcare Conference in San Francisco, January 13\u201316, 2025. At both Biotech Showcase and RESI JPM, BullFrog AI will highlight its proprietary BullFrog Data Networks\u00ae, a data insights tool powered by the bfLEAP\u2122 platform. BullFrog Data Networks\u00ae evaluate high-dimension, multi-modal data in specific disease indications, providing a customized, visual representation of previously unknown relationships and pathways. The networks &hellip; Continue reading &quot;BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-10T13:08:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTg4MSM2Njg4MDk2IzIyNTU4NDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week\",\"datePublished\":\"2025-01-10T13:08:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\\\/\"},\"wordCount\":691,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyOTg4MSM2Njg4MDk2IzIyNTU4NDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\\\/\",\"name\":\"BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyOTg4MSM2Njg4MDk2IzIyNTU4NDk=\",\"datePublished\":\"2025-01-10T13:08:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyOTg4MSM2Njg4MDk2IzIyNTU4NDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyOTg4MSM2Njg4MDk2IzIyNTU4NDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/","og_locale":"en_US","og_type":"article","og_title":"BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week - Market Newsdesk","og_description":"GAITHERSBURG, Md., Jan. 10, 2025 (GLOBE NEWSWIRE) &#8212; BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (&#8220;BullFrog AI&#8221; or the &#8220;Company&#8221;), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its participation in the TechBio track at Biotech Showcase and RESI JPM, both taking place during the annual JP Morgan Healthcare Conference in San Francisco, January 13\u201316, 2025. At both Biotech Showcase and RESI JPM, BullFrog AI will highlight its proprietary BullFrog Data Networks\u00ae, a data insights tool powered by the bfLEAP\u2122 platform. BullFrog Data Networks\u00ae evaluate high-dimension, multi-modal data in specific disease indications, providing a customized, visual representation of previously unknown relationships and pathways. The networks &hellip; Continue reading \"BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-10T13:08:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTg4MSM2Njg4MDk2IzIyNTU4NDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week","datePublished":"2025-01-10T13:08:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/"},"wordCount":691,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTg4MSM2Njg4MDk2IzIyNTU4NDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/","name":"BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTg4MSM2Njg4MDk2IzIyNTU4NDk=","datePublished":"2025-01-10T13:08:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTg4MSM2Njg4MDk2IzIyNTU4NDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyOTg4MSM2Njg4MDk2IzIyNTU4NDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/799504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=799504"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/799504\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=799504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=799504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=799504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}